Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00416286
First received: December 25, 2006
Last updated: December 26, 2006
Last verified: December 2006
  Purpose

The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.


Condition Phase
Healthy
Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 30
  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Exclusion Criteria:

  • Children under 12y old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00416286

Contacts
Contact: Doron Harari, DMD 972-2-6776169 dharari@cc.huji.ac.il

Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Doron Harari, DMD Orthodontic department, Dental school Hadassah Ein Kerem
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00416286     History of Changes
Other Study ID Numbers: 26-23.12.05-HMO-CTIL, 26-23.12.05, code: 1371
Study First Received: December 25, 2006
Last Updated: December 26, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
Cetylpyridinium chlorid
Sustained release
orthodontic patients
streptococcus mutans
Lactobacillus
Rate of bacterial load in saliva of orthodontic patients

Additional relevant MeSH terms:
Cetylpyridinium
Anti-Infective Agents, Local
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on July 23, 2014